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Abstract
Introduction
Loss of annulus fibrosus (AF) integrity predisposes to disc herniation and is associated with
IVD degeneration. Successful implementation of biomedical intervention therapy requires
in-depth knowledge of IVD cell biology. We recently generated unique clonal human
nucleus pulposus (NP) cell lines. Recurring functional cellular phenotypes from indepen-
dent donors provided pivotal evidence for cell heterogeneity in the mature human NP. In
this study we aimed to generate and characterize immortal cell lines for the human AF from
matched donors.
Methods
Non-degenerate healthy disc material was obtained as surplus surgical material. AF cells
were immortalized by simian virus Large T antigen (SV40LTAg) and human telomerase
(hTERT) expression. Early passage cells and immortalized cell clones were characterized
based on marker gene expression under standardized culturing and in the presence of
Transforming Growth factor β (TGFβ).
Results
The AF-specific expression signature included COL1A1, COL5A1, COL12A1, SFRP2 and
was largely maintained in immortal AF cell lines. Remarkably, TGFβ induced rapid 3D sheet
formation in a subgroup of AF clones. This phenotype was associated with inherent differ-
ences in Procollagen type I processing and maturation, and correlated with differential
mRNA expression of Prolyl 4-hydroxylase alpha polypeptide 1 and 3 (P4HA1,3) and Lysyl
oxidase (LOX) between clones and differential P4HA3 protein expression between AF cells
in histological sections.
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Conclusion
We report for the first time the generation of representative human AF cell lines. Gene
expression profile analysis and functional comparison of AF clones revealed variation
between immortalized cells and suggests phenotypic heterogeneity in the human AF.
Future characterization of AF cellular (sub-)populations aims to combine identification of
additional specific AF marker genes and their biological relevance. Ultimately this knowl-
edge will contribute to clinical application of cell-based technology in IVD repair.
Introduction
The intervertebral disc consists of the central nucleus pulposus (NP), which is encircled by the
ligamentous annulus fibrosus (AF), and bordered by two flanking (superiorly and inferiorly)
cartilaginous end plates (CEPs). The AF is a fibrous tissue with distinct layers of highly ori-
ented Collagen fibers (lamellae) that run in alternating directions at an angle of approximately
30 degrees [1]. The unique structure and composition of the AF contains the compressed NP
and, in addition, allows the spine to cope with bending and torsional forces [2]. Further mor-
phological distinction is made between the inner and outer AF layers. The extra cellular matrix
(ECM) of the outer AF mainly consists of fibrillar Collagens such as Collagen type I, while the
inner AF contains lower amounts of Collagen type I [3]. A gradual increase of Collagen type II
and Proteoglycan expression towards the nucleus pulposus further distinguishes the inner AF
from the outer AF [3]. The AF is firmly attached to both CEPs [4]. From a clinical perspective,
the NP has received considerable attention, as the degenerative processes that accompany disc
pathologies are first clinically detected in the NP [5]. However, early pathologies including disc
herniation crucially depend on AF integrity. Recent studies indicate that disc herniation does
not correlate well with NP degeneration, suggesting that additional factors are involved, includ-
ing specific aspects of cell biology in both the NP and the AF [5, 6].
Cell density in the AF and NP are low compared to other tissues (± 9000 and 3000 cells/
mm3, respectively) [7]. Cells in the AF originate from sclerotome-derived mesenchymal cells
and are often referred to as chondrofibroblast-like cells, based on morphological characteristics
[8]: the outer AF contains cells with an elongated (fibroblast-like) morphology, whereas cells of
the inner AF cells display a more rounded (chondrocyte-like) morphology [9]. It is currently
unclear whether these cells represent developmentally distinct lineages or whether the local
micro-environment determines morphologically and/or functionally divergent phenotypes. It
has been suggested that NP cells are recruited to the inner AF and produce collagen type II and
Proteoglycans [10], although this idea has been contradicted by recent lineage tracking studies
in mice [11, 12]. In analogy with this, morphological conversion of fibroblast-like toward chon-
drocyte-like cells in the inner AF was described during embryonic AF development in the rat
[13] and furthermore the understanding of AF cell heterogeneity is limited [14]. Isolated primary
AF cells from healthy or degenerate discs have been used to assess cellular responses to growth
factors, inflammatory stimulation and mechano-transduction [15–17]. In addition, such primary
cell isolates have been used in combination with biomaterials for disc tissue engineering [18, 19].
Since it is currently unclear how distinct AF cell phenotypes contribute to disc homeostasis and
disease, such studies lack functional definition. Establishment of functionally diverse AF cell lines
represents a relevant experimental approach to study cell heterogeneity in the AF.
The cells that compose the AF represent a crucial component of the healthy IVD and are
involved in disc pathology [20]. Therefore, a detailed understanding of the native AF cell popu-
lation is imperative to acquire full insight into their involvement in disc pathology and a
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thorough knowledge of the AF cell population was recently defined as one of the main chal-
lenges for successful AF repair [21]. As such we here aimed to generate immortal clonal cell
models to enhance studies of the human AF cell population and to test the idea that phenotypi-
cally distinct AF cell populations can be isolated and immortalized.
Materials and Methods
Isolation of intervertebral disc cells, cell culture and immortalization
Briefly, non-degenerative healthy disc material was obtained as surplus material from correc-
tion surgery (MUMC, Medical Ethical Review Committee approval 08-4-021; by Dutch law,
informed patient consent is part of the MERC approval and not required separately from next
of kin, caretakers, or guardians on behalf of others; all consent was based on the approval
obtained from the local MERC; see Table 1). To obtain primary AF cell isolates, AF tissue was
collected during scoliosis correction surgery performed on two young individuals (donor 1:
D1; donor 2: D2; Table 1). Tissue samples were macroscopically dissected in AF and NP
tissue with omission of the inner AF and transition zone. Isolation of IVD cells was described
in detail elsewhere [22]. Cells were cultured in maintenance / control medium (Control:
DMEM-F12/Glutamax (Gibco), 10% fetal calf serum (FCS; Biowhittaker, cat no DE14-801F),
1% antibiotic/antimycotic (Gibco), 1% non-essential amino acids (NEAA; Gibco)). Initial cell
seeding was performed at a density of 30,000 cells/cm2 in culture plates (Greiner). Upon con-
fluency (P0) cultures were expanded as “pools” (1:2 to P5) to obtain sufficient material for ini-
tial characterization. A detailed description of the immortalization protocol and proof of
immortalization was described previously [22]. Briefly, immortalized cell pools were generated
from P5 cells by serial transduction of primary cells with retroviral particles carrying coding
sequences for SV40LTAg and human telomerase (hTERT). Single cell clones were derived by
limiting dilution and cell clones were expanded individually. After immortalization and clonal
expansion D2-derived cells showed a proliferation rate more similar to that of the parental
lines [22]; for this reason experiments were continued with D2-derived cell clones. When
monolayer AF cultures were grown in medium containing TGFβ, 30,000 cells/cm2 were plated
and incubated the next day (t = 0) with DMEM/F12, 1% antibiotic/antimycotic, 1% Insulin/
Transferrin/Sodium Selenite (ITS; Gibco), 50 μg/ml Ascorbic acid-2-Phosphate-deoxycholate
(Sigma-Aldrich), 1 ng/ml TGFβ3 (Gibco PHG9305) and 1% NEAA, for the indicated time
period. Seeding at this density resulted in a confluent dish one day post-plating. Phase contrast
images were taken with a Nikon Eclipse TE200 microscope using available imaging software.
Table 1. IVD donor characteristics and clones.
Donor* gender age medical indication position IVD AF clones
D1 F 15 idiopathic scoliosis T7-T10 36
D2 M 13 spina biﬁda/scoliosis T6-L1 34
Tissues were obtained from young adolescent scoliosis patients who received correction surgery. In contrast to herniated or adult discs, these
intervertebral discs showed no signs of disc degeneration with intact annulus ﬁbrosis tissue surrounding clear lucid nucleus pulposi; both tissues types
were macroscopically clearly distinguishable.
*: Donor isolates D1 and D2 in this manuscript correspond to donors D4 and D5, respectively; patient characteristics have recently been published [23].
The total number of generated clones is indicated in column “AF clones”.
F = Female
M = Male, age in years at the time of surgery, discs obtained
T = thoracic
L = lumbar intervertebral discs.
doi:10.1371/journal.pone.0144497.t001
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(Immuno)histochemistry of IVD tissue sections
IVD tissue from above correction surgery was decalcified in formalin/EDTA and dehydrated
following standard procedures. Next sections were embedded in paraffin. Tissue sections were
cut at 5 μm and positioned on Superfrost Plus slides (Thermo Scientific). Prior to histochemis-
try, sections on slides were deparafinized and rehydrated using standard protocols. Safranin O
(0.1%) was used to stain proteoglycans and counterstaining was performed with Fast Green
(0.1%). The stained sections were dehydrated and mounted in Histomount (Thermo, Runcorn,
Cheshire, UK) for microscopic analysis. For immunohistochemical analysis human IVD tissue
was obtained from a deceased donor (45 year old male), with no history of back pain or other
relevant clinical history during post-mortem examination (written informed consent was
obtained from the donor’s relatives and approval for the study was granted by the local ethics
committee: North West Research Ethics Committee). Representative tissue biopsies were pro-
cessed to paraffin wax and immunohistochemical staining performed on 5 μm sections as pre-
viously described [23]. Briefly, sections were deparafinized, rehydrated and heat-mediated
antigen retrieval performed using 10 mM Tris/1mM EDTA, pH9 at 95°C for 10 minutes in a
steamer. Endogenous peroxidase was blocked using 3% hydrogen peroxide in TBS for 1 hr and
non-specific binding sites blocked with 25% normal goat serum in TBS for 45 minutes. Sections
were incubated overnight at 4°C with rabbit polyclonal primary antibody for P4HA3 (1:100 in
1% BSA in TBS; Sigma, HPA007897). Biotinylated goat anti-rabbit secondary antibody was
used, and staining was disclosed using Vectastain Elite ABC Reagent and a diaminobenzidine
chromogen. The negative control used the appropriate IgG (Dako) in place of the primary anti-
body at equal protein concentration. Stained sections were viewed under light microscopy, and
images were acquired using an InfinityX camera with DeltaPix software. Alternatively, sections
was scanned using the Pannoramic 250 Flash II digital slide scanner (3DHistech1) and visual-
ised using the Pannoramic Viewer software (3DHistech1).
RNA isolation and quantitative real time PCR
To isolate RNA, cells were disrupted in Trizol (Invitrogen). RNA isolation, RNA quantification
(UV)-spectrometry (Nanodrop, Thermo Scientific), and cDNA synthesis were performed as
described before [24]. Real-time quantitative PCR (RT-qPCR) was performed using Mesagreen
qPCR master-mix plus for SYBR1 Green (Eurogentec). Validated primer sets used are
depicted in Table 2. An Applied Biosystems ABI PRISM 7700 Sequence Detection System was
used for amplification: initial denaturation 95°C for 10 min, followed by 40 cycles of DNA
amplification. Data were analyzed using the standard curve method and normalized to Cyclo-
phillin B (PPIB) mRNA levels.
Protein extraction and immunoblotting
Protein extraction and immunoblotting were performed and analyzed as described previously
with minor adjustments [25]. For extraction, cells were lysed in RIPA buffer (50 mM Tris-HCl
pH 8.0, 150 mMNaCl, 0.1% SDS, 5 mM EDTA, 0.5% w/v Sodium Deoxycholate, and 1% NP-
40) supplemented with protease and phosphatase inhibitors (Roche). Lysates were sonicated
on ice using the Soniprep 150 MSE at amplitude 10 for 14 cycles (1 second on/1 second off).
Insoluble material was removed by centrifugation (10 minutes, 16000x g, 4°C). Protein concen-
tration was determined using a BCA protein assay kit (Pierce/Thermo Fisher Scientific). Pro-
teins samples were separated by SDS-PAGE and transferred to Nitrocellulose membranes
(Protran BA-8). Membranes were blocked (1 hour, 5% non-fat dry milk powder (Campina),
ambient temp), and incubated with primary antibodies (overnight, 4°C). Antisera: polyclonal goat
anti-COL1A1 (1310–01; Southern Biotech), mouse monoclonal β-Actin (clone C4, 08691001; MP
New AF Cell Models for In Vitro Studies
PLOS ONE | DOI:10.1371/journal.pone.0144497 January 21, 2016 4 / 19
Biomedicals, Santa Ana, CA, USA), mouse monoclonal α-Tubulin (clone B-5-1-2, T6074; Sigma-
Aldrich). Secondary antisera: polyclonal rabbit anti-goat (P0449; Dako Cytomation, Glostrup,
Denmark), rabbit anti-mouse (P0260; Dako). Signals were detected using enhanced chemolumi-
nescence. X-ray films were scanned and analyzed with Quantity One (Biorad).
Cell assays (proliferation, DNA)
At each indicated time point cells were washed and fixed (3.7% formaldehyde/PBS, 10 minutes,
ambient temperature), rinsed with demineralized water, stained (0.1% Crystal violet, 30 min-
utes, ambient temperature) and washed with demineralized water. Crystal violet was extracted
with 10% acetic acid; absorbance was determined at 590 nm (Benchmark, Biorad).
Statistics
Statistical significance (p< 0.05) was determined by two-tailed student t tests. To test for nor-
mal distribution of input data, D’Agostino–Pearson omnibus normality tests were performed.
All quantitative data sets presented passed the normality tests. In Figs 1 and 2 a two-tailed stu-
dent t test was used and in Figs 3, 4 and 5 a one-tailed student t test was used as only a positive
difference was expected. Gene expression analyses show mean and standard deviation.
Results
AF cell isolation and basic AF cell characteristics
Tissue from two independent young donors that was clearly distinguishable as outer AF (Fig
1A; Table 1) was carefully selected and dissected for this purpose, to avoid cell contamination
by other IVD tissue types (i.e. inner AF/transition zone, NP). Safranin-O/Fast Green staining
Table 2. Quantitative PCR primer list.
symbol gene name forward primer reverse primer
ACAN Aggrecan GCAGCTGGGCGTTGTCA TGAGTACAGGAGGCTTGAGGACT
ADAMTS17 ADAM with thrombospondin type I motif 17 AATTTGGCCTTTACCATCGCC CGTGGTTCATGCCCAAGTTGT
BMP1 Bone morphogenetic protein 1 CCTCCCCTGAA-ACCCCAAT CCCGGGTGTGACAGAGATG
COL1A1 Collagen type I, Collagen α1 TGGAGAGTACTGGATTGACCCC TGCAGAAGACTTTGATGGCATC
COL2A1 Collagen type II, Collagen α1 TGGGTGTTCTATTTATTTATTGTCTTCCT GCGTTGGACTCACACCAGTTAGT
COL5A1 Collagen type V, Collagen α1 GATGTCGCTTACAGAGTCACCAA AAATGCAGACGCAGGGTACAG
COL12A1 Collagen type XII, Collagen α1 TGACAACCCTTTCCGACACA CTCCTCACGGTTCTAAAATTTGC
COMP Cartilage oligomeric matrix protein CAAGGCCAACAAGCAGGTTTG CAGTTATGTTGCCCGGTCTCA
PPIB Cyclophillin B CCTGCTTCCACCGGATCAT CGTTGTGGCGCGTAAAGTC
LOX Lysyl oxidase TAGCCACTATGACCTGCTTGATG AACTTGCTTTGTGGCCTTCAG
P4HA1 Prolyl 4-hydroxylase, alpha polypeptide 1 CCCATTTTGACTTTGCACGG CCCCAGCTCTTTGAAAGCATC
P4HA2 Prolyl 4-hydroxylase, alpha polypeptide 2 TCAAACTGACACCCCGTAGACA TGTTGCCATGGTGGTACCTACA
P4HA3 Prolyl 4-hydroxylase, alpha polypeptide 3 GGAGCCACAGCCTTCATCTATG ATTCCTAACCACAGGCAGCT
PLOD1 Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 ATGGCCTTCTGTGCCAACAT CGGTTGGTCAGGAACATGAAC
PLOD2 Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 AGCGTTCTCTTCGTCCTCATCA TTTGCAACCACCTCCCTGAA
PLOD3 Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 TTTCCCGGTTACCACACCAAG CCGGTAGCGAACCACAAAGTT
SFRP2 Secreted frizzled-related protein 2 TGTGCCACGGCATCGA TCGTGGCCCAGCAGGTT
SOX9 SRY-box 9 AGTACCCGCACCTGCACAAC CGCTTCTCGCTCTCGTTCAG
TLL1 Tolloid-like 1 ATTCTCCCCTCCCGTGATG GACGGGTTCGCTGACCAAT
Validated real time primer sets for the indicated genes that were subjected to quantitative PCR analysis in this study.
doi:10.1371/journal.pone.0144497.t002
New AF Cell Models for In Vitro Studies
PLOS ONE | DOI:10.1371/journal.pone.0144497 January 21, 2016 5 / 19
of paraffin sections from tissue samples confirmed that the selected AF tissue displayed typical
AF morphology: radial layers of alternately oriented Collagen fibers, cells of elongated mor-
phology aligned parallel to the fibers and increasing glycosaminoglycan content toward the NP
(Fig 1B).
Cells from dissected AF tissues were enzymatically released from their ECM and allowed to
adhere to culture plates. AF cell morphology in monolayer cultures was similar to previous
reports [26] and primary AF and NP cell cultures showed consistent morphological features
(primary AF cells were slightly more rounded, while NP cells showed a typical wave-like pat-
terning), independent of donor (Fig 1C). We aimed to confirm tissue of origin prior to immor-
talization by measuring expression of putative AF markers; candidate markers were selected
Fig 1. Confirmation of AF cell phenotype in vitro. A)Representative image of a human IVD tissue specimen from a scoliosis donor. The relevant tissue
zones are indicated; the dotted box indicates, by approximation, the tissues section used for AF cell isolation.B) Safranin O/Fast Green staining of AF tissue
from a scoliosis donor at 25x (left image) and 100x magnification (right image). Bars indicate 200 μm. C) Phase-contrast images of primary NP and AF cell
pools from donor 1 (D1) and from donor 2 (D2) at passage 5 (P5). Primary AF cells were slightly more rounded, while NP cells showed a typical wave-like
patterning. Bars indicate 20 μm. D)Gene expression analysis of the putative AFmarkersCOL1A1, COL5A1, SFRP2, COL12A1 and ADAMTS17 in primary
AF (white bars) and NP (black bars) cell isolates from donor 1 D1(P5) and donor 2 D2(P5), respectively; gene expression was normalized toCyclophillin B
mRNA levels and data is presented relative to expression in NP cells. Statistical significance was assessed by Student’s t-test * p<0.05.
doi:10.1371/journal.pone.0144497.g001
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based on highest fold differential expression and on marker overlap among these studies [27–
30]. NP cells that had been isolated simultaneously from adjacent NP tissue were used in com-
parative expression studies to independently establish distinctive in vitromorphology and gene
expression phenotypes. Expression of most previously reported AF marker genes COL1A1 [27,
30], COL5A1 [27] and COL12A1 [30] was at least 2 fold higher in primary AF cultures of two
independent donors as compared to matched NP cultures at passage 5 (P5) (Fig 1D). The puta-
tive AF marker SFRP2 [29] was exclusively expressed in primary AF cells (Fig 1D). In addition,
Fig 2. Clonal phenotypes of AF cell lines. A) Phase-contrast images of two representative AF cell clones 102 and 133 (D2) under normal, (i.e. non-
differentiation) maintenance conditions. Cell clones showed preferential cell-cell contacts and alignment at 1–2 days post-plating. Time points in days are
indicated after seeding 6,400 cells/cm2 at day zero; the t = 0 image represents 12 hours post-plating. Bars indicate 20 μm. B) Spectrometric quantification of
Crystal violet staining assays, reflecting growth of eleven immortalized cell clones. Every dot represents the average value of a biological triplicate
measurement for a single clone. Mean values and standard deviations are depicted for eleven independent clones. At approximately 6 days post-plating
(P10), a plateau was reached due to confluence of the cell cultures.C)Gene expression analysis ofCOL1A1, COL2A1, COMP, ACAN, SOX9 and the novel
AF markersCOL5A1, COL12A1, SFRP2. Every dot represents a single clone and shows the average of a biological triplicate measurement. Mean
expression values and standard deviations are depicted per marker gene for eleven clones. Gene expression values were normalized to Cyclophillin B
mRNA levels.
doi:10.1371/journal.pone.0144497.g002
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we found differential expression of ADAMTS17: NP cells consistently expressed lower
ADAMTS17 levels (Fig 1D). NP-specific marker expression analysis was published elsewhere
[22]. This initial data thus confirms distinctive tissue of origin of primary AF and NP cells.
Cell line generation and characterization of AF cell clones
A total of 70 cell clones (Table 1) were obtained from immortalized P5 cells that displayed a
comparable fibroblastic morphology (Fig 2A), in agreement with published reports [31, 32].
Eleven randomly chosen clones showed nearly similar proliferation rates with an average pop-
ulation doubling time (PDL) of 50.71 hours in the exponential phase (Fig 2B).
To evaluate whether cell clones retained an AF-specific marker expression profile, we mea-
sured expression of genes associated with a chondrocyte-like phenotype: COL2A1, SOX9 and
ACAN [33]. In addition we evaluated the articular chondrocyte marker COMP, which was not
Fig 3. TGFβ3-induced sheet formation in a subgroup of AF clones. A) Phase contrast images of AF-S clones 102, 115, 126 and AF-nS clones 119, 123,
133 (from D2) at t = 0 and cultured in control medium (Control) or TGFβ3 containing medium (+ TGFβ3) for 7 days. Bars represent 20 μm. Cells did not exhibit
sheet formation in control medium. B)Gene expression analyses of COL1A1, COL5A1, COL12A1 and SFRP2 in immortal AF cell clones. Every dot
represents a single clone and is the average of a biological triplicate measurement. Gene expression was normalized to cyclophillin BmRNA levels. Fold
induction (t = 7 TGFβ3 / t = 0) was calculated for each clone separately. Mean and standard deviations are depicted for the three clones together per gene.
Statistical significance was assessed by Student’s t-test; * p<0.05.
doi:10.1371/journal.pone.0144497.g003
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expressed in the NP or the AF [27]. A ratio 800:1 of COL2A1 over COL1A1mRNA has previ-
ously been established as a measure to differentiate between NP and AF cells [34]. Immortal
AF cell clones indeed showed higher levels of COL1A1mRNA compared to COL2A1mRNA
(Fig 2C; average ratio 2.5:1). SOX9mRNA levels were relatively low, yet detectable in all tested
clones, which is in accordance with an earlier publication [35]. COMP and ACAN mRNA levels
were very low/absent, in good agreement with an AF cell phenotype [36]. We evaluated
whether primary AF marker gene expression profiles, established in Fig 1C, were retained in
immortal AF cell clones. The AF markers COL1A1, COL5A1, COL12A1 and SFRP-2 were
expressed in AF cell clones, except for ADAMTS17 (Fig 2C). Absolute mRNA expression levels
of our defined set of AF markers (COL5A1, COL12A1, SFRP2) were higher than COL1A1,
Fig 4. Collagen processing determines the sheet forming capacity in AF clones. A) Immunoblot analyses of Collagen type I protein in AF-S and AF-nS
clones cultured in control or TGFβ3 containing medium for 7 days. Procollagen-alpha 1 (180 kDa; pro-α1) and Procollagen alpha 2 (145 kDa; pro-α2) variants
of Collagen type I are indicated. The appearance of mature alpha 1 (135 kDa; α1) and alpha 2 (120 kDa; α2) variants of Collagen type I correlated well with
sheet formation in AF-S clones. β-Actin (βACT) was used as loading control.B) Immunoblot analyses of Collagen type I protein in AF-S clones cultured in
TGFβ3 medium with or without ascorbic acid for 7 days. Alpha-tubulin (αTUB) was used as loading control. C)Quantification of Collagen maturation as a
function of time in AF-S and AF-nS clones. The ratio of mature COL1A1 over ProCOL1A1 and mature COL1A2 over ProCOL1A2 are depicted in the left and
right graphs, respectively. At t = 0 no mature forms of Collagen type I were detectable. Statistical significance was assessed by Student’s t-test; * p<0.05.
doi:10.1371/journal.pone.0144497.g004
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COL2A1, ACAN and SOX9mRNA levels (Fig 2C). Although morphological differences among
clones were not readily discernable, marker gene expression levels were relatively heteroge-
neous between cell clones (Fig 2C).
Functional differences between AF cell clones
Transforming growth factor beta 3 (TGFβ3) is a well-known morphogen used to induce ECM
synthesis of AF cells [37]. We previously showed that a medium containing TGFβ3 induced
divergent responses in primary AF and NP cells [22]. Therefore the AF cell clones were cul-
tured in this TGFβ containing medium. We observed the formation of three-dimensional ECM
Fig 5. Collagenmodifying enzymes are transcriptionally regulated by TGFβ3 in sheet forming AF clones.Upper panels: expression analysis of
P4HA1-3 genes in AF-S and AF-nS clones at t = 0 and t = 7 days of culturing in TGFβ3. Middle panels: expression analysis of PLOD1-3 genes in AF-S and
AF-nS clones at t = 0 and t = 7 days of culturing in TGFβ3. Lower panels: expression analysis of genes involved in cleavage of Collagen type I pro-peptides
(BMP1, TLL1) and crosslinking of Collagen fibers (LOX) in AF-S and AF-nS clones at t = 0 and t = 7 days of culturing in TGFβ3. Gene expression was
normalized to cyclophillin BmRNA levels. Fold induction (t = 7 TGFβ3 / t = 0) was calculated for each clone separately. Mean and standard deviations are
depicted for the three clones together per gene. Statistical significance was assessed by Student’s t-test; * p<0.05.
doi:10.1371/journal.pone.0144497.g005
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structures within seven days after exposure to TGFβ (Fig 3A). Importantly, a subset of clones:
AF-102, AF-115 and AF-126 formed a 3D cellular “sheet” within seven days, whereas clones
AF-119, AF-123 and AF-133 showed dissimilar sheet formation and contraction dynamics
within this timeframe. Based on the differential dynamics in sheet formation, AF clones will be
referred to as AF-S (sheet-forming) and AF-nS (non sheet-forming) from hereon. As sheet for-
mation in vitro has been associated with Collagen formation [38], mRNA levels of Collagens
COL1A1, COL5A1 and COL12A1mRNA were determined (Fig 3B). Basal expression levels of
COL1A1, COL5A1 and COL12A1mRNA were not different between the two groups of sub-
clones, COL5A1 exempted: 2 out of 3 representative AF-nS clones expressed higher basal
COL5A1 levels. Expression of the COL1A1 and COL12A1markers was increased as a result of
seven days exposure to TGFβ3 in both AF-S and AF-nS clones. COL5A1mRNA expression
was higher in 2 out of 3 clones in AF-S clones, whereas overall expression levels in AF-nS had
not changed. Of note, SFRP2, a previously reported putative AF marker, was strongly down
regulated in all clones under these conditions. Thus, although differences in sheet formation
were evident between clones, expression of Collagen genes per se did not explain the divergent
ability to form 3D sheets.
The macroscopically detectable formation of contracting Collagenous cell sheets indicated
that Collagen maturation may be involved in sheet formation, as has been reported in other
studies [38]. The formation of clearly visible fibers in phase-contrast images precedes contrac-
tion of cell sheets. We therefore tested for potential differences in Collagen maturation between
the AF clones. COL1A1 maturation and processing was visualized by immunoblotting.
COL1A1 protein appears in two forms: alpha1 and alpha2. Two alpha 1 chains and one alpha 2
chain form one Collagen type I triple-helical molecule [39]. The N- and C-terminal domains in
Procollagen prevent fiber formation upon assembly of Collagen molecules. Collagen molecules
undergo various post-translational modifications during maturation and processing [39].
Upon secretion into the ECM, these pro-domains are enzymatically removed to allow fiber for-
mation [39]. The ascorbic acid-dependent formation of hydroxylated proline residues stabilizes
the Collagen molecule and propels formation of larger Collagen networks [40, 41]. Immuno-
blotting revealed clear maturation of Collagen type I alpa1 and -alpha2 in clones AF-102, AF-
115 and AF-126 cell lysates grown in the presence of TGFβ3 (Fig 4A). Within the same time-
frame, fragments corresponding to mature Collagen molecules could not be detected in clones
AF-119, AF-123 and AF-133 (Fig 4A). Thus, differential sheet formation in the presence of
TGFβ3 correlated with COL1A1 maturation. To determine whether the observed effects
depended on ascorbic acid-mediated formation of mature Collagen type I, AF-S clones were
grown in the presence of TGFβ3 in medium containing ascorbic acid or not. Relevantly,
TGFβ3-induced Procollagen maturation does not occur in AF-S clones in the absence of ascor-
bic acid (Fig 4B). Consistent with this observation, sheet formation did not occur in the absence
of ascorbic acid (data not shown).
Differential processing of Procollagen type I (ProCOL1) in the different subsets of AF clones
was quantified in a more detailed time course experiment. Three representative clones for each
group were exposed to TGFβ3 for 0, 2, 4, 6 or 8 days. To obtain additional evidence for a diver-
gent ability to process Collagens, ratios of mature/Procollagen were determined for COL1A1
and COL1A2 as a function of time by immunoblotting and subsequent densitometry. Procolla-
gens began to be processed within 2 days of culturing in the presence of TGFβ3, as they became
detectable by immunoblotting at this time point (data not shown). Within 4 and 6 days of cul-
turing, a clear trend towards significantly different COL1A1/ProCOL1A1 ratios between AF-S
and AF-nS became apparent (Fig 4C). At 8 days of TGFβ3 exposure, the COL1A1/ProCOL1A1
(Fig 4C, left panel) and COL1A2/ProCOL1A2 (Fig 4C, right panel) ratios were substantially
increased (as compared to t = 2) and significantly higher in AF-S clones, compared to AF-nS
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clones (Fig 4C). This collective data thus far suggests that Collagen type 1 maturation and pro-
cessing in AF-S clones is strongly associated with a more rapid sheet formation and detach-
ment than in AF-nS clones.
To further examine the origin of the differential Procollagen processing observed between
AF-S and AF-nS clones, we measured the expression of genes encoding proteins involved in
Procollagen processing- and post-translational modification of Collagen. The enzymes Prolyl
4-hydroxylase alpha polypeptide 1, 2 and 3 (P4HA1-3) are responsible for the formation of
hydroxyproline groups on Collagen molecules in the endoplasmatic reticulum (ER) [42]. Con-
sistent with enhanced Collagen processing, AF-S cell clones showed an increased expression of
P4HA1, P4HA2 and P4HA3 of 4, 6 and 10 fold, respectively (Fig 5, top panels). In sharp con-
trast, P4HA1-3 gene expression was non-responsive to TGFβ3 in AF-nS clones. Prolyl hydrox-
ylase gene expression thus correlated strongly with sheet forming capacity in AF-S cells. The
Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1, 2 and 3 (PLOD1-3) enzymes catalyze the
hydroxylation of lysyl residues of Collagen peptides in the ER and these residues are critical for
the formation of intramolecular crosslinks. The expression levels of PLOD1 was significantly
increased in both AF-S and AF-nS clones under TGFβ3 conditions; all three PLOD genes
showed a trend toward higher expression in AF-S clones (Fig 5, middle left panel). Subse-
quently we measured two genes involved in extracellular Procollagen cleavage. Tolloid-like 1
(TLL1) and Bone Morphogenic Protein-1 (BMP-1) are responsible for extra-cellular C-termi-
nal Procollagen cleavage, while ADAMTS2 is involved in N-terminal cleavage. Both TLL1 and
BMP1 expression was significantly induced in AF-S and AF-nS clones by TGFβ3 containing
medium at day 7 (Fig 5, bottom panels). ADAMTS2 expression did not show any (differential)
response to TGFβ3 (data not shown). Absence of consistent expression differences between
AF-S and AF-nS for these genes suggests that these genes may not play a significant role in the
observed divergent sheet formation capacity between AF subclones. Lysyl oxidase (LOX) is
located in the extracellular environment and involved in covalent crosslinking of Collagen net-
works. LOX expression was significantly induced in AF-S (average 5 fold) and decreased in
AF-nS cell clones (2 fold). LOX expression was significantly different between AF-S and AF-nS
clones at t = 7. The clearly significant fold change between AF-S and AF-nS clones for the
genes P4HA1, P4HA3, PLOD1 and LOX indicate an inherent difference in the ability of AF cell
clones to process Procollagen molecules.
Finally we sought evidence for P4HA3 marker expression at the protein level in vivo. Immu-
nohistochemical staining of IVD tissue showed fibroblastic AF cells staining positive for
P4HA3 in both the inner and outer AF (Fig 6). Importantly not all cells were positive, particu-
larly in the outer AF, where cells with similar morphology did not detectably express P4HA3.
Thus the data presented herein supports inherent cell heterogeneity or different cell states in
the native human AF.
Discussion
In this study we aimed to generate the first stable in vitro cell models representing the human
AF. First, we established an AF gene expression signature that discriminates cultured primary
AF cells from primary NP cells. Subsequently, we immortalized AF cell pools from two inde-
pendent donors and generated a total of seventy clonal cell lines. We characterized eleven ran-
dom AF cell clones based on the AF gene signatures and a number of additional genes
routinely employed in IVD research. The immortal cell clones maintained an AF phenotype
which was largely comparable to primary AF cells. Using medium containing TGFβ3 [37] [43]
that was previously used to differentiate primary AC and NP cells [22, 24], we were able to dif-
ferentiate between two subsets of immortal AF clones based on their ability to process
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COL1A1: AF-S subclones rapidly produced mature Collagen forms that propelled 3D cellular
sheet formation and contraction, while a second group of AF clones (AF-nS) did this to a
much lower extent. Relevantly, several genes known to be involved in the post-translational
modification and processing of Collagen were more prominently induced in AF-S clones.
Based on these results, we speculate that our immortalization procedures provides proof for
the existence of at least two functionally different cell states in the outer AF that differ in their
ability process to Collagen type I. Further research on identifying unique cellular markers may
elucidate if these characteristics represent different AF cell types or different (dormant and
activated) cell states. Combined with our earlier report on the establishment of functionally dis-
tinct NP cell types, our current data support the notion that in vivo the AF and NP harbor a
heterogeneous cell population.
AF cell heterogeneity in vitro and in vivo
The finding that phenotypically distinct AF cell populations exist in vitro paves the way for in
vivo discovery of additional AF cell subtypes. Senescent and non-senescent AF cells are known
to be present in the IVD in vivo [44, 45]. It is important to note that the retrovius-based
immortalization procedure employed is biased toward immortalization of proliferating cells.
Hence it is anticipated that not all possible AF cell phenotypes were immortalized, most nota-
bly terminally differentiated, non-proliferative cells. SV40LTAg, which interferes with pRB and
TP53 function, and hTERT prevent senescent responses. This response may be important for
mechanisms leading to disc degeneration. Although SV40LTAg may affect cell phenotype and
differentiation characteristics [46], we did not detect differences in proliferation or marker
gene expression between the AF cell subtypes reported herein prior to stimulation with TGFβ.
Relevantly, cellular phenotypes of neuronal cells are retained by immortalization with
SV40LTAg and hTERT [47]. Although we cannot formally rule out an effect of SV40LTAg
and/or hTERT on AF cell responses under the culture conditions used herein, the data thus far
Fig 6. P4HA3 positivity in AF tissue is heterogeneous. Expression of P4HA3 was determined immunohistochemically in human AF tissue.
Representative images of outer AF (left panel) and inner AF (right panel) from a 45 year old male donor with no signs of disc degeneration. Asterisks:
representative examples of immune-positive cellsl circles: immune-negative cells. Black bars represent 50 μm.
doi:10.1371/journal.pone.0144497.g006
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suggest that the phenotypic variation arises despite immortalization. Future experiments with
conditionally immortalized models may further improve the representation of IVD cell lines.
The observed differential capacity of single AF cell clones to process Collagens in vitro is an
indication that AF cell heterogeneity exists. This is supported by immunohistochemical studies
showing diversity in the AF cell morphology and orientation [9, 14]. Two distinct cellular sub-
populations, an elongated and a rounded cell type have been described in the embryonic rat AF
[9]; it is however not clear how cell morphology relates to Collagen fibrillogenesis at this time
point in development. In the bovine AF three cellular subtypes were described: 1) extended
cordlike cells that form an interconnected network at the periphery of the disc, 2) cells with
extensive, sinuous processes in the inner region of the annulus fibrosus and 3) cells with broad,
branching processes specific to the interlamellar septae of the outer annulus [14]. It is conceiv-
able that such cell types differ in their ability to synthesize and or process Collagens. Detailed
molecular characterization and marker identification is crucial to elucidate if different cell
types exist or that dormant and activated cell states are present.
AFmarker expression
Putative marker genes for AF cells have been reported in several array expression studies of
varying tissue origin [27–30]. However most of these reported AF marker genes were not vali-
dated by qPCR. COL1A1 and in particular the ratio of expression with COL2A1 has been used
to discriminate AF from NP cells. We confirmed that COL1A1, COL5A1, COL12A1, SFRP-2
and ADAMTS17 expression levels positively discriminate AF from NP cultures. ADAMTS17
and COL5A1 were previously found to be expressed in human AF cells [48]. The vast expres-
sion difference for SFRP2 in AF and NP cultures was surprising as this marker appears to be
rather unique for AF cultures. Although we find ADAMTS17 expression in primary AF cells,
the expression of this marker was reduced in immortal clones. Although the exact reason for
the diminished ADAMTS17 expression is not known at this moment, it is conceivable that
expression of this marker requires the presence of and interaction of cells with a specific AF
environment. Alternatively, cells expressing these markers may not have been immortalized.
ADAMTS17, which encodes a protein involved in Collagen processing, was differentially
expressed between AF and NP in primary cells from both donors (3 fold higher in AF). SOX9
expression was found in all evaluated AF clones. SOX9 expression is a well described marker
for chondrocytes and the expression in every clone, which was derived from a single cell, sup-
ports the idea that AF cells harbor a phenotype akin to chondrocyte-like cells. Based on the
observation that subcloned (i.e. single cell–derived) cell lines express these markers, we would
propose that the AF does not contain mixtures of chondrocytes and fibroblasts per se, but
rather that individual AF cells intrinsically harbor expression characteristics of both.
Since there is no clear-cut definition of the AF phenotype, consensus on the morphogens
and the conditions required for AF(-like) differentiation is lacking. We utilized a routinely
employed culture medium. One important constituent, TGFβ3, is widely used in chondrocyte
studies and fibroblasts are often stimulated with this growth factor to study fibrosis [37, 43,
49]. Moreover, we observed that this medium evoked a differential response between AF and
NP cultures [22, 24]. Similar to our previously reported observations in NP cell clones, the
expression of novel marker genes (e.g. SFRP2) was decreased in the presence of TGFβ3 con-
taining medium [22, 24]. The function of these novel marker genes in the IVD has not been
established and therefore their down-regulation in response to standard chondrogenic media
cannot currently be explained. It is conceivable that TGFβ3 forces these cells to adopt a pheno-
type in vitro which does not occur in vivo. Additional comparative studies using different mor-
phogens is required to elucidate optimal AF cell differentiation conditions.
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Collagen maturation as a distinguishing feature among AF subclones
Collagen fiber formation was reported to be dose-dependently regulated by ascorbic acid [50].
Secretion of Collagen is thought to be a rate limiting step in Collagen fibrillogenesis [51]. The
inherent difference in the capacity of groups of AF clones to process Collagens is an indication
of AF cell heterogeneity. Previously TGFβ was shown to induce collagen fibrillogenesis in rat
an bovine AF cells in micromasses and electrospun scaffolds, respectively [15, 47]. Sheet forma-
tion only occurred in the presence of TGFβ, indicating the collagen maturation/fibrillogenesis
largely depends on TGFβ signaling. Sheet formation in AF-S clones started approximately 4–5
days after TGFβ exposure and completely detached ECM sheets could always be observed at 6
days after TGFβ exposure. On average AF-nS clones initiated weak contraction (at which time
±10% of the surface was detached) of the ECM sheet at 5 days after start of TGFβ exposure and
did not show detached cellular sheets before day 8 after start of TGFβ exposure. The clear cor-
relation of sheet formation in AF-S clones with the expression of P4HA1, P4HA2, P4HA3,
PLOD1 and LOX, demonstrates their involvement in Collagen fiber formation and matrix con-
traction. Matrix contraction is rarely investigated: one study used smooth muscle cells in com-
bination with a Collagen type I coating to induce matrix contraction within 24 hours [52].
MMP inhibition prevented matrix contraction while ascorbic acid and other anti-oxidants
were unable to prevent contraction [52]. Hence, we speculate that sheet formation occurs rap-
idly, perhaps in conjunction with a certain critical Collagen fiber mass or cell density, under
the influence of Collagen modifying enzymes. Interestingly ascorbic acid-induced sheet forma-
tion has only recently been reported in studies using mesenchymal stem cells [53]. These cell
sheets were shown to promote the differentiation towards various lineages [54, 55]. An obvious
caveat in the interpretation of these results is that mRNA levels do not necessarily reflect
enzyme activity. Importantly, we here report clear differences in Collagen processing between
AF subclones at the protein (i.e. functional) level.
In contrast to post-translational modification of proteoglycan molecules, which have been
extensively studied in the IVD [13], relatively little is known with respect to post-translational
modification of Collagen and its turnover in the intervertebral disc. The biochemical distribu-
tion of Collagen molecules varies massively depending on the location in the IVD (NP, inner
AF, outer AF, CEP). It is conceivable that cells from the various layers of the AF differentially
depend on their capacity to process Collagens for the maintenance of their specific surrounding
matrix. A thorough study of Collagen post-translational modifications in the various compart-
ments of the IVD might help provide possible answers.
Conclusion
Structural integrity of the annulus fibrosus is a condicio sine qua non for intervertebral disc sta-
bility and function. Nevertheless research on low back pain and the process of disc degenera-
tion has predominantly focused on the nucleus pulposus, as this is the tissue where the first
signs of disc degeneration occur [56]. The importance of the annulus fibrosus for disc degener-
ation and pathologies was recently highlighted in several studies [6, 20]. In particular the AF
cell phenotype remains largely undefined [21]. In this study we have generated the first immor-
tal human AF cell lines that will enable studying AF cell biology with the advantages of a cell
model. In addition, these clonogenic cells display differences in collagen fibril formation in the
context of TGFβ exposure. The appearance of contracting collagen matrices in monolayer cul-
tures correlates to expression of P4HA1, P4HA3 and LOX. This difference in collagen fibril for-
mation suggests differences in cell phenotype in vitro. Additional AF cell markers, preferably
located at the cell surface to aid cell purification, are needed to further study and define the rel-
evance of AF cell phenotypes in vivo and in disc degeneration. Increased understanding of AF
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cell biology will contribute to the development of novel approaches to treat AF defects and will
further increase our understanding of IVD tissue homeostasis.
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